scispace - formally typeset
B

Biwen Peng

Researcher at Wuhan University

Publications -  69
Citations -  1537

Biwen Peng is an academic researcher from Wuhan University. The author has contributed to research in topics: Medicine & Viral replication. The author has an hindex of 19, co-authored 59 publications receiving 1063 citations.

Papers
More filters
Journal ArticleDOI

A review on the pharmacological effects of vitexin and isovitexin.

TL;DR: This review summarized recent findings on various pharmacological activities and associative signalling pathways of vitexin and isoviteXin to provide a reference for future research and clinical applications.
Journal ArticleDOI

Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.

TL;DR: It is demonstrated that severe memory deficits occurred in the late phase of EAE, and cognitive deficits were ameliorated by treatment with MCC950, an inhibitor of the NLRP3 inflammasome, which provides a novel therapeutic strategy for hippocampal impairment in EAE and MS.
Journal ArticleDOI

Modulation of neuroinflammation: Role and therapeutic potential of TRPV1 in the neuro-immune axis

TL;DR: The literature supports the hypothesis that TRPV1 may represent potential therapeutic targets in the neuro-immune axis and evidenced that inflammation modulates the expression and activity of TRpV1 in the central nervous system (CNS) and TRPv1 exerts reciprocal actions over neuroinflammatory processes.
Journal ArticleDOI

Vitexin reduces hypoxia–ischemia neonatal brain injury by the inhibition of HIF-1alpha in a rat pup model

TL;DR: The data indicate early HIF-1α inhibition with vitexin provides both acute and long-term neuroprotection in the developing brain after neonatal HI injury, as seen by decreased infarct volume evaluated at 48 h post-HI.
Journal ArticleDOI

A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China.

TL;DR: The hypothesis that VP1 acts as a sandwich switch for viral particle stabilization and cellular receptors attachment, and specific mutations in this protein can convert mild cases into severe cases is led to.